When universal testing was implemented, 40% of the tested residents were positive for SARS-CoV-2.
Universal COVID-19 testing of residents of 11 Maryland long-term care facilities found that close to 40% of the residents were infected with the SARS-CoV-2 virus, according ot a research report published in JAMA Internal Medicine.
The authors, led by Benjamin F. Bigelow, at Johns Hopkins, say their results show that symptom-based testing is not adequate to identify cases in long-term facilities and inform efforts to control or prevent outbreaks.
Testing only of residents with symptoms identified 153 cases within 20 days of thge detection of an index case in the nursing homes, they report.
When the remaining 893 residents were tested, 354 (39.6%) were postive for the SARS-CoV-2 virus that causes COVID-19.
The total number of positive cases in the nursing home was 507, and more than half (55.4%) were asymptomatic.
The testing used the standard nasopharyngeal swab sample and then reverse-transcriptase PCR test to see if the sample showed evidence of infection.
Follow-up universal testing of 426 residents at seven of the nursing homes identified 177 cases and of those, 154 (87%) were asymptomatic. Twenty of the peope who were asymptomatic when they tested positive were eventually hospitalized, and 7 (4.6%) died within 14 days of testing.
Unrealistic Portrayals of Cardiac Arrest in Contemporary Film | ACC 2025
March 31st 2025Cardiac arrests in contemporary film are largely inaccurate when it comes to survival rate and etiology, according to a poster presented today at the American College of Cardiology conference held March 29 to 31 in Chicago.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Winrevair Reduced Risk of Morbidity and Mortality by 76% in PAH | ACC 2025
March 31st 2025In the ZENITH trial, Winrevair was evaluated based on a composite endpoint of all-cause death, lung transplantation or disease-related hospitalization for patients with pulmonary arterial hypertension.
Read More
Clopidogrel Beat Aspirin in Preventing Heart Attacks After PCI | ACC 2025
March 31st 2025Clopidogrel monotherapy may be an alternative to aspirin for prevention of cardiac events in high-risk patients after percutaneous coronary intervention, according to a new study presented at ACC 2025.
Read More